Correlation Between Transcode Therapeutics and Gracell Biotechnologies
Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and Gracell Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and Gracell Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Transcode Therapeutics and Gracell Biotechnologies, you can compare the effects of market volatilities on Transcode Therapeutics and Gracell Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of Gracell Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and Gracell Biotechnologies.
Diversification Opportunities for Transcode Therapeutics and Gracell Biotechnologies
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Transcode and Gracell is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and Gracell Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gracell Biotechnologies and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with Gracell Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gracell Biotechnologies has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and Gracell Biotechnologies go up and down completely randomly.
Pair Corralation between Transcode Therapeutics and Gracell Biotechnologies
Given the investment horizon of 90 days Transcode Therapeutics is expected to under-perform the Gracell Biotechnologies. In addition to that, Transcode Therapeutics is 2.77 times more volatile than Gracell Biotechnologies. It trades about -0.01 of its total potential returns per unit of risk. Gracell Biotechnologies is currently generating about 0.06 per unit of volatility. If you would invest 287.00 in Gracell Biotechnologies on August 24, 2024 and sell it today you would earn a total of 115.00 from holding Gracell Biotechnologies or generate 40.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 32.06% |
| Values | Daily Returns |
Transcode Therapeutics vs. Gracell Biotechnologies
Performance |
| Timeline |
| Transcode Therapeutics |
| Gracell Biotechnologies |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Transcode Therapeutics and Gracell Biotechnologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Transcode Therapeutics and Gracell Biotechnologies
The main advantage of trading using opposite Transcode Therapeutics and Gracell Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, Gracell Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gracell Biotechnologies will offset losses from the drop in Gracell Biotechnologies' long position.| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
| Gracell Biotechnologies vs. Monte Rosa Therapeutics | Gracell Biotechnologies vs. Design Therapeutics | Gracell Biotechnologies vs. Erasca Inc | Gracell Biotechnologies vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |